Autoimmune Dementia:Clinical Course and Predictors of Immunotherapy Response.

submitted by: mcgheekkm

Autoimmune dementia and encephalopathy represents an exciting and rapidly evolving field of “treatable” and “potentially reversible” neurological disorders. Dr Sean Pittock, MD, a consultant in the Division of MS and Autoimmune Neurology at the Mayo Clinic discusses the findings of a recent study investigating the clinical predictors of immunotherapy responsiveness in patients with presumed Autoimmune Dementia.